- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2014
- Public Summary Document (PSD) March 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2014 PBAC Meeting - Word
Erlotinib – March 2014
Erlotinib, 25 mg tablet, 30, 100 mg tablet, 30 and 150 mg tablet, 30, Tarceva®, Roche Products Pty Limited
Last updated
8 November 2023